+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 65Years - 85Years
All Genders
ID05877846

A Pilot Study of Beta-Hydroxy-Methylbutyrate and Vitamin D to Improve Physical Function in Older Adults Aged 65 to 85 Years

Led by University of North Carolina, Chapel Hill · Updated on 2026-02-17

25

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the effects of beta-hydroxy-methylbutyrate HMB supplementation on physical function in older adults aged 65 to 85 years. This pilot, single-arm study lasting 12 weeks aims to assess how feasible and acceptable the intervention and study procedures are. The study also evaluates changes in physical function and explores multi-omics patterns to describe physical function phenotypes in this population. Participants will take HMB with vitamin D3 capsules twice daily for 12 weeks. If a participants vitamin D3 levels are above 80 ngdL, they will receive HMB capsules without vitamin D3 instead. The intervention is designed to be flexible based on vitamin D3 levels and will be provided after initial screening and testing. During the study, participants will undergo various assessments including physical function tests such as sit-to-stand, grip strength, gait speed, and 400-meter walk, cognitive tests, dietary assessments, and imaging scans MRI and ultrasound. Blood and stool samples will be collected to analyze metabolomic and inflammatory markers. The study will monitor safety, attendance, and adherence, with outcome measurements taken at baseline, 6 weeks, and 12 weeks. The total study period extends about one year for screening and data collection following the 12-week intervention.

CONDITIONS

Brief Title

Precision Medicine and Physical Function

Research Team

D

Danae C Gross, MS

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here